Research
What the RECORD Registry Found About ECG Monitoring After TAVR
By Sameer Sontakey
The observational RECORD registry examined 14-day ambulatory ECG monitoring after TAVR. Its findings describe an association with fewer serious events, not proof that monitoring prevents sudden cardiac death.
TL;DR: The observational RECORD registry found fewer serious cardiovascular events in the group receiving 14-day ambulatory ECG monitoring after TAVR. It does not prove that monitoring caused the difference or prevents sudden cardiac death. Monitoring decisions belong with the treating cardiology team.1
What Is TAVR and Why Does the Heart Need Monitoring After?
TAVR (transcatheter aortic valve replacement) replaces an aortic valve using a catheter rather than open-heart surgery. The choice of procedure depends on an individual clinical assessment.
Authoritative sources
TAVR places a new valve near the heart’s conduction system. Conduction disturbances can appear after discharge, which is why post-procedure follow-up may include ambulatory ECG monitoring.2
Why Does TAVR Disrupt the Heart’s Electrical System?
Think of the heart’s electrical system like traffic lights: every chamber waits for its signal before it pumps. Those signals travel through a relay station that sits right next to where the new valve lands.
Valve placement can affect nearby conduction tissue. Conduction disturbances vary in severity; complete heart block can be a medical emergency.2
What Heart Rhythm Problems Can Happen After TAVR?
Several types of rhythm problems can appear after the procedure, ranging from mild to life-threatening.2
- Left bundle branch block (LBBB): A delay or block in conduction on the left side of the heart’s electrical system.
- AV block: A signal that has trouble reaching the lower heart. Mild forms are common. Severe forms can cause fainting or cardiac arrest.
- Complete heart block: The signal is fully cut off. The lower heart beats on its own at 20 to 40 times per minute — a medical emergency.
- Atrial fibrillation (AFib): An irregular beat in the upper heart. It raises stroke risk and often causes no symptoms at all.
Some rhythm disturbances are intermittent. A brief ECG may not capture an episode that occurred at another time. The appropriate monitoring method and duration depend on clinical assessment.
What Did the RECORD Registry Find?
The RECORD registry analysis included 1,217 people who underwent TAVR and were discharged without a permanent pacemaker.1 Two groups were compared:
- 211 people wore a heart monitor patch for 14 days after discharge.
- 1,006 people underwent TAVR during the three years before and after the registry period without systematic ambulatory ECG monitoring.
The primary endpoint combined sudden cardiac death, syncope or presyncope due to symptomatic arrhythmias, and stroke at one year:
- Serious event rate in the monitored group: 1.9%
- Serious event rate in the standard-care group: 6.6%
- The reported adjusted hazard ratio was 0.27 (95% confidence interval, 0.10–0.74; p = 0.011).1
All sudden cardiac deaths occurred in the control group.1 The comparison was observational, not randomized, and valve use differed between groups. These findings cannot establish that a patch prevented deaths; the authors called for a randomized trial.
AFib Diagnoses in the RECORD Registry
New-onset AFib was diagnosed in 8.9% of the monitored group versus 1.8% of the control group.1
The study reported new oral anticoagulation in 71.4% of these cases. Stroke rates at one year were similar between groups.1
Who Is at the Highest Risk After TAVR?
Mangieri et al. studied delayed advanced conduction disturbances in a single-center TAVR cohort. Baseline right bundle branch block and the increase in PR interval after TAVR were independent predictors of late permanent pacemaker implantation in that analysis.6
Auffret et al.’s review also discusses prior right bundle branch block, valve type, and implantation depth as risk factors for conduction disturbances.2 These findings inform clinical assessment; they do not determine an individual follow-up plan on their own.
Who Should Get 14-Day Heart Monitoring After TAVR?
The RECORD registry studied a 14-day monitoring approach, but an observational comparison does not establish that everyone should receive the same protocol.1
The treating cardiology team should determine monitoring duration and follow-up based on the person’s clinical findings and applicable guidance.
The Bottom Line
Conduction disturbances can occur after TAVR. The RECORD registry found an association between systematic ambulatory ECG monitoring and fewer serious cardiovascular events, but a randomized trial is needed to establish whether monitoring improves outcomes.1
If you or someone you care for has had TAVR, ask the treating cardiology team about the follow-up plan before discharge.